Diabetic retinopathy
- PMID: 20580421
- DOI: 10.1016/S0140-6736(09)62124-3
Diabetic retinopathy
Abstract
Diabetic retinopathy is a common and specific microvascular complication of diabetes, and remains the leading cause of preventable blindness in working-aged people. It is identified in a third of people with diabetes and associated with increased risk of life-threatening systemic vascular complications, including stroke, coronary heart disease, and heart failure. Optimum control of blood glucose, blood pressure, and possibly blood lipids remains the foundation for reduction of risk of retinopathy development and progression. Timely laser therapy is effective for preservation of sight in proliferative retinopathy and macular oedema, but its ability to reverse visual loss is poor. Vitrectomy surgery might occasionally be needed for advanced retinopathy. New therapies, such as intraocular injection of steroids and antivascular endothelial growth-factor agents, are less destructive to the retina than are older therapies, and could be useful in patients who respond poorly to conventional therapy. The outlook for future treatment modalities, such as inhibition of other angiogenic factors, regenerative therapy, and topical therapy, is promising.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Update on the treatment of diabetic retinopathy.Hong Kong Med J. 2007 Feb;13(1):46-60. Hong Kong Med J. 2007. PMID: 17277392 Review.
-
Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.Prescrire Int. 2010 Feb;19(105):35-8. Prescrire Int. 2010. PMID: 20455344 Review.
-
[Angiopathy and the eye].Vnitr Lek. 2010 Apr;56(4):333-9. Vnitr Lek. 2010. PMID: 20465107 Review. Czech.
-
Management of proliferative diabetic retinopathy.Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
-
Management of diabetic retinopathy.Indian J Ophthalmol. 2000 Dec;48(4):321-30. Indian J Ophthalmol. 2000. PMID: 11340894 Review.
Cited by
-
Understanding inherent image features in CNN-based assessment of diabetic retinopathy.Sci Rep. 2021 May 6;11(1):9704. doi: 10.1038/s41598-021-89225-0. Sci Rep. 2021. PMID: 33958686 Free PMC article.
-
Optical coherence tomography angiography analysis of changes in the foveal avascular zone in eyes with diabetic macular edema treated with intravitreal anti-vascular endothelial growth factor.Int J Retina Vitreous. 2022 Aug 26;8(1):57. doi: 10.1186/s40942-022-00406-z. Int J Retina Vitreous. 2022. PMID: 36028899 Free PMC article.
-
FABP4 Is an Indispensable Factor for Regulating Cellular Metabolic Functions of the Human Retinal Choroid.Bioengineering (Basel). 2024 Jun 7;11(6):584. doi: 10.3390/bioengineering11060584. Bioengineering (Basel). 2024. PMID: 38927820 Free PMC article.
-
Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating AMPK/Nrf2/HO-1 pathway.Immun Inflamm Dis. 2022 Dec;10(12):e698. doi: 10.1002/iid3.698. Immun Inflamm Dis. 2022. PMID: 36444632 Free PMC article.
-
Validation of a New Diabetic Retinopathy Knowledge and Attitudes Questionnaire in People with Diabetic Retinopathy and Diabetic Macular Edema.Transl Vis Sci Technol. 2020 Sep 30;9(10):32. doi: 10.1167/tvst.9.10.32. eCollection 2020 Sep. Transl Vis Sci Technol. 2020. PMID: 33062395 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
